Evidence map›Paper›PMID 22782974›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2012

Promoter methylation confers kidney-specific expression of the Klotho gene.

Masahiro Azuma, Daisuke Koyama, Jiro Kikuchi, Hiromichi Yoshizawa, Dissayabutra Thasinas, Kazuhiro Shiizaki, Makoto Kuro-o, Yusuke Furukawa, Eiji Kusano

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. [Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Determination of the Relationship Between DNA Methylation Status ofBalkan journal of medical genetics : BJMG · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. CCL5 Suppresses Klotho ExpressionFrontiers in physiology · 2022
    Article
  16. Phosphate and Cellular Senescence.Advances in experimental medicine and biology · 2022
    Article
  17. Review
  18. Epigenetic modifications of Klotho expression in kidney diseases.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Masahiro AzumaDepartment of Internal Medicine, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan.
Daisuke Koyama
Jiro Kikuchi
Hiromichi Yoshizawa
Dissayabutra Thasinas
Kazuhiro Shiizaki
Makoto Kuro-o
Yusuke Furukawa
Eiji Kusano
Jichi Medical University · JPThe University of Texas Southwestern Medical Center · US

Funding

Klotho and Phosphate in Chronic Kidney Disease: Pathogenesis and TherapeuticsR01DK091392 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI HU, MING-CHANG, MOE, ORSON W · 2011 to 2021
$3.2M
NIDDK NIH HHS R01 DK091392NIDDK NIH HHS R01-DK091392
6 · The paper itself

Abstract

The aging suppressor geneKlotho is predominantly expressed in the kidney irrespective of species. Because Klotho protein is an essential component of an endocrine axis that regulates renal phosphate handling, the kidney-specific expression is biologically relevant; however, little is known about its underlying mechanisms. Here we provide in vitro and in vivo evidence indicating that promoter methylation restricts the expression of the Klotho gene in the kidney. Based on evolutionary conservation and histone methylation patterns, the region up to -1200 bp was defined as a major promoter element of the human Klotho gene. This region displayed promoter activity equally in Klotho-expressing and -nonexpressing cells in transient reporter assays, but the activity was reduced to ∼20% when the constructs were integrated into the chromatin in the latter. Both endogenous and transfected Klotho promoters were 30-40% methylated in Klotho-nonexpressing cells, but unmethylated in Klotho-expressing renal tubular cells. DNA demethylating agents increased Klotho expression 1.5- to 3.0-fold in nonexpressing cells and restored the activity of silenced reporter constructs. Finally, we demonstrated that a severe hypomorphic allele of Klotho had aberrant CpG methylation in kl/kl mice. These findings might be useful in therapeutic intervention for accelerated aging and several complications caused by Klotho down-regulation.

Indexed as

AnimalsCell LineDNA MethylationGlucuronidaseHumansImmunoblottingKidneyKlotho ProteinsMiceMice, KnockoutPromoter Regions, GeneticReverse Transcriptase Polymerase Chain ReactionGlucuronidaseKlotho Proteins

Identifiers

PMID22782974
PMCPMC3448772
OpenAlexW2170534823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.